Concord Biotech Ltd
NSE:CONCORDBIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Concord Biotech Ltd
NSE:CONCORDBIO
|
IN |
|
Jefferies Financial Group Inc
NYSE:JEF
|
US |
|
Comtech Telecommunications Corp
NASDAQ:CMTL
|
US |
Wall St Price Targets
CONCORDBIO Price Targets Summary
Concord Biotech Ltd
According to Wall Street analysts, the average 1-year price target for CONCORDBIO is 1 181.5 INR with a low forecast of 1 030.2 INR and a high forecast of 1 338.75 INR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CONCORDBIO's stock price target?
Price Target
1 181.5
INR
According to Wall Street analysts, the average 1-year price target for CONCORDBIO is 1 181.5 INR with a low forecast of 1 030.2 INR and a high forecast of 1 338.75 INR.
What is the Revenue forecast for Concord Biotech Ltd?
Projected CAGR
18%
Over the last 4 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 7 years is 18%.
What is the Operating Income forecast for Concord Biotech Ltd?
Projected CAGR
14%
Over the last 4 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is 14%.
What is the Net Income forecast for Concord Biotech Ltd?
Projected CAGR
12%
Over the last 4 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 3 years is 12%.
